Mothers and CareGivers Investing in Children Study 2.0

Description

The study will use a longitudinal, randomized control trial design to determine intervention impact on parent and child behaviors, and infant health. The two intervention groups include: 1) MAGIC-FEED+; and 2) MAGIC-SAFE. This trial is an efficacy trial of the MAGIC-FEED and MAGIC-SAFE program that has been successfully implemented with families as part of the MAGIC 1.0 program trial (IRB#: 2015040017). * The primary aim is to investigate each intervention's impact on infant BMIZ at 13 months. * The investigators will also assess the effect of MAGIC-FEED on caregiver nutrition knowledge and feeding practices, responsive feeding, infant diet, and child self-regulatory abilities and assess how these factors impact child self-regulation of eating and adiposity. * Finally, the investigators will determine if the interventions demonstrate the factors necessary to be a successful intervention as determined by the RE-AIM and PRISM frameworks.

Conditions

Childhood Obesity Prevention, Parenting Behavior, Infant Growth

Talk to us

Study Overview

On this page

Study Details

Study overview

The study will use a longitudinal, randomized control trial design to determine intervention impact on parent and child behaviors, and infant health. The two intervention groups include: 1) MAGIC-FEED+; and 2) MAGIC-SAFE. This trial is an efficacy trial of the MAGIC-FEED and MAGIC-SAFE program that has been successfully implemented with families as part of the MAGIC 1.0 program trial (IRB#: 2015040017). * The primary aim is to investigate each intervention's impact on infant BMIZ at 13 months. * The investigators will also assess the effect of MAGIC-FEED on caregiver nutrition knowledge and feeding practices, responsive feeding, infant diet, and child self-regulatory abilities and assess how these factors impact child self-regulation of eating and adiposity. * Finally, the investigators will determine if the interventions demonstrate the factors necessary to be a successful intervention as determined by the RE-AIM and PRISM frameworks.

Mothers and CareGivers Investing in Children: MAGIC 2.0

Mothers and CareGivers Investing in Children Study 2.0

Condition
Childhood Obesity Prevention
Intervention / Treatment

-

Contacts and Locations

Austin

Sarah M. & Charles E. Seay Building, Austin, Texas, United States, 78712

Austin

Dell Pediatric Research Institute, Austin, Texas, United States, 78723

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * A singleton infant 3-6 weeks of age, born ≥37 weeks gestation.
  • * The mother and other caregiver must be at least 18 years of age.
  • * The infant must live with the mother.
  • * Lives within the Austin metropolitan area.
  • * English or Spanish speaking.
  • * The primary caregiver must identify as the mother.
  • * Infant diagnosed with major physical disabilities and/or medical condition that affects feeding and growth, and/or born \<37 weeks gestation.
  • * Infant experienced NICU stay \>7 days.
  • * Twins, triplets, or other multiples.
  • * Mothers and/or other caregivers younger than 18 years old.
  • * Mothers that do not consent to being video recorded with their baby.
  • * Families that do not speak either English or Spanish will be excluded from this study. Families that only speak English or Spanish, or families that speak English or Spanish and another language, will be accepted.
  • * Do not plan to remain in Austin area for the next two years.

Ages Eligible for Study

0 Years to 90 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Texas at Austin,

Elizabeth Widen, PhD, RD, PRINCIPAL_INVESTIGATOR, UT Austin

Deborah Jacobvitz, PhD, PRINCIPAL_INVESTIGATOR, UT Austin

Study Record Dates

2029-12-31